Pressure BioSciences, Inc. (PBIO) Reports Revenue Hike in Q3, While Achieving Its Best Financial Quarter in Two Years; Company Expects Strong 2021
Measurable success achieved in Q3 2020 in key financial, operational, and technical projects Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt Q3 total revenue exceeded Q1 and Q2 total revenue combined Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track to be released in mid-2021 Alliance with Leica Microsystems over PBI’s proprietary pressure cycling technology (“PCT”) platform has the potential to accelerate cancer R&D and subsequent drug development using an innovative tumor processing workflow Pressure BioSciences (OTCQB: PBIO) is a leader in the development, marketing,…